Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.
Doses of 30 mg of ceforanide or cefamandole per kg were administered intravenously to 26 patients just before their chests were opened for coronary artery bypass or cardiac valve replacement surgery. Samples of right atrial appendage, pericardial fluid, plasma, aortic wall, intercostal muscle, and sternum were obtained at different times after the antibiotic was injected, and these samples were assayed for cephalosporin concentration. For ceforanide the pre-bypass plasma half-life was 2.5 h, and the atrial appendage half-life was 2.1 h; for cefamandole the pre-bypass plasma half-life was 0.75 h and the atrial appendage half-life was 0.72 h. At 3 h the concentrations of ceforanide and cefamandole in atrial appendages were 28.0 and 5.0 micrograms/g, respectively. Ceforanide achieved higher and more sustained concentrations in other tissues than cefamandole. Considering the minimal inhibitory concentrations of these drugs for staphylococci, cefamandole and ceforanide should provide adequate protection against infection by these organisms for the duration of the surgical procedure.
D006348:Cardiac Surgical Procedures; D002435:Cefamandole / Q000031:analogs & derivatives / Q000378:metabolism*; D002511:Cephalosporins / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010490:Pericardial Effusion / Q000378:metabolism; D010496:Pericardium / Q000378:metabolism; D011292:Premedication; D012272:Ribs; D013203:Staphylococcal Infections / Q000517:prevention & control*; D013249:Sternum / Q000378:metabolism
D002511:Cephalosporins; D002435:Cefamandole; C012653:ceforanide